European Companies Search Engine
EU funding (€832,500): Targeting IRE1 in disease Hor11 Nov 2016 EU Research and Innovation programme "Horizon"
Overview
Text
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: MannKind Corporation, Danbury, United States.
The visualizations for "MANNKIND CORPORATION - EU funding (€832,500): Targeting IRE1 in disease"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
